Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Clayton Kaiser

Thoracic Surgery (Cardiothoracic Vascular Surgery) Nashville, TN Medical Doctor

NPI 1003077728 CMS profile 590859

4230 Harding Pike Ste 530, Nashville, TN 37205

Open in the dashboard

General payments

$124,475

179 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$43,084 paid to institutions, not to them · program year 2019

Through program year 2025, Clayton Kaiser of Nashville, TN is reported in the CMS Open Payments database as having received $124,475 across 179 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $43,084 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $48,112 49
2024 General $46,108 56
2023 General $21,595 24
2022 General $2,495 20
2021 General $4,515 11
2020 General $661 6
2019 General $989 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Clayton Kaiser
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Clayton Kaiser were reported at $48,112. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Clayton Kaiser Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $989 $886 $178–$3,167 $163
2020 $661 $341 $108–$1,605 $114
2021 $4,515 $453 $125–$1,886 $132
2022 $2,495 $695 $180–$2,566 $149
2023 $21,595 $745 $205–$2,662 $160
2024 $46,108 $799 $214–$2,967 $164
2025 $48,112 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $71,561 66 payments
  2. Edwards Lifesciences Corporation $25,318 31 payments
  3. Helios Cardio Inc $20,548 9 payments
  4. Abbott Laboratories $2,311 31 payments
  5. W. L. Gore & Associates, Inc. $1,814 11 payments
  6. Abiomed $877 6 payments
  7. Medtronic Vascular, Inc. $505 8 payments
  8. Dilon Technologies, Inc. $370 3 payments
  9. Medtronic, Inc. $277 3 payments
  10. Boston Scientific Corporation $262 4 payments
  11. Other $632 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $60,500 15 payments
  2. Consulting Fee $41,465 7 payments
  3. Travel and Lodging $12,073 53 payments
  4. Food and Beverage $8,937 102 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,500 2 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System Surgery $68,561 65 payments
  2. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $21,542 4 payments
  3. CARDIAMEND $20,548 9 payments
  4. Da Vinci Surgical System Surgery $3,000 1 payment
  5. EPIC $1,778 27 payments
  6. GORE TAG Thoracic Endoprosthesis $1,726 6 payments
  7. PASCAL $1,170 13 payments
  8. Impella $877 6 payments
  9. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $705 7 payments
  10. Endurant $416 4 payments
  11. Other $2,338 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

74

Median for Cardiac Surgery: 68

Drug cost

$529

Median for Cardiac Surgery: $445

Branded share of claims

0%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mupirocin Generic 74 $529

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$190,450

Medicare's payments for the services billed

Medicare patients

274

Average age 75

Services billed

438

95 women, 179 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 54%
Atrial fibrillation 47%
Diabetes 45%
Arthritis 45%
Chronic kidney disease 38%
COPD 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

179 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record